Psyllogel
Commercial- Indications
- Constipation, Diarrhea
Company intelligence / Profile preview
Nathura S.p.A.
Italynathura.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Nathura S.p.A. has established itself as a market leader in Italy for food supplements and medical devices targeting bowel well-being, sleep disorders, and women’s health. Its products are commercially available in Italy and being introduced to international markets. The company was acquired by Giuliani S.p.A. No clinical trial data typical of pharmaceutical development was found; the company operates primarily in consumer healthcare with over-the-counter products.
- Therapeutic areas
- GastroenterologyDermatologyNeurologyWomen's Health
- Modalities
- Food supplementsmedical devices (not traditional drug modalities like small molecules or mAbs)
- Industry
- Food & Nutrition
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Nathura S.p.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nathura S.p.A..